AEVA three-lens brief
Evidence-based stock research on AEVA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +4.65% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved +4.65% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 8.2pp over 30 days.
- Analyst mean target $24.80 — 93% above current (5 analysts).
- Negative free cash flow last quarterly (-$57.40M).
AEVA closed at $12.84 (+4.65%) as of 2026-11-12. Market cap: $897.47M. Price is below the 50-day MA and below the 200-day MA. Positives: moved +4.65% yesterday.; analyst mean target $24.80 — 93% above current (5 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 8.2pp over 30 days.. Last quarter: Revenue $6.67M, net income $4.45M, free cash flow -$57.40M.
Why three lenses on AEVA, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AEVA across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AEVA" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AEVA brief"></iframe>